How Long Can Wegovy Stay Out of the Fridge: The Complete Temperature Stability Guide for Semaglutide Pens

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Unopened Wegovy pens can stay out of the fridge for up to 28 days at room temperature (59°F to 86°F), but must be discarded after that window even if unused
• Once a pen is opened (first injection taken), it can be stored at room temperature or in the fridge for up to 56 days total
• Exposure above 86°F or below 32°F (freezing) permanently damages the medication, even if returned to proper storage afterward
• Visual inspection alone cannot confirm potency loss; degraded semaglutide often looks identical to fresh medication

Direct answer (40-60 words)

Wegovy can stay out of the fridge for up to 28 days if unopened, or up to 56 days once opened (first dose taken), as long as the temperature stays between 59°F and 86°F. After these windows, the medication must be discarded. Freezing or exposure above 86°F permanently destroys potency, even if the pen looks normal.

Table of contents

1. The official Novo Nordisk storage guidelines
2. What most articles get wrong about the 28-day rule
3. Unopened vs opened pens: why the storage windows differ
4. The temperature stability data: what happens at 77°F, 86°F, and 95°F
5. The FormBlends travel pattern: what we see in real-world storage failures
6. How to tell if your Wegovy pen is still safe to use
7. The decision tree: can I still use this pen?
8. What happens if you inject degraded semaglutide
9. Travel and emergency storage: the working protocol
10. Compounded semaglutide vs brand Wegovy: storage differences
11. When refrigeration failure means you need a replacement
12. FAQ

The official Novo Nordisk storage guidelines

Novo Nordisk, the manufacturer of Wegovy, publishes specific storage requirements in the prescribing information and on the product label. These are the FDA-reviewed stability limits:

Unopened pens (never used):

• Store in refrigerator at 36°F to 46°F (2°C to 8°C)
• May be stored at room temperature (59°F to 86°F / 15°C to 30°C) for up to 28 days
• After 28 days at room temperature, discard the pen even if no doses have been taken
• Do not freeze; if frozen, discard immediately

Opened pens (after first injection):

• Store in refrigerator or at room temperature (59°F to 86°F)
• Use within 56 days of first use
• Keep the pen cap on when not in use to protect from light
• Do not store with needle attached

Always:

• Protect from excessive heat and sunlight
• Do not store in car glove compartments, near windows, or in direct sunlight
• Do not use if the solution appears cloudy, discolored, or contains particles

The 28-day and 56-day limits are based on stability testing showing maintained potency within those windows. Beyond those limits, Novo Nordisk cannot guarantee the medication retains full effectiveness.

What most articles get wrong about the 28-day rule

The most common error in online content about Wegovy storage is conflating the unopened 28-day limit with the opened 56-day limit. Many articles state "Wegovy can be out of the fridge for 28 days" without specifying that this applies only to unopened pens.

The confusion stems from comparing Wegovy to Ozempic (also semaglutide, also made by Novo Nordisk). Ozempic has a 56-day room-temperature window for both opened and unopened pens. Wegovy's unopened limit is shorter (28 days), likely because the higher-dose formulation (up to 2.4 mg vs Ozempic's 2 mg max) has different stability characteristics at room temperature.

Here's the correct breakdown:

Pen status	Refrigerated storage	Room temp storage (59-86°F)	Total usable life
Wegovy, unopened	Indefinite (until expiration date)	28 days max	Until expiration or 28 days after leaving fridge
Wegovy, opened	Up to 56 days	Up to 56 days	56 days from first injection
Ozempic, unopened	Indefinite (until expiration date)	56 days max	Until expiration or 56 days after leaving fridge
Ozempic, opened	Up to 56 days	Up to 56 days	56 days from first injection

The practical implication: if you receive a Wegovy pen in the mail and it sits on your counter for 4 weeks before you open it, you must discard it. If you open it on day 1 and then leave it on the counter, you have 56 days to use it.

A second common error is assuming visual inspection can confirm potency. Semaglutide degradation is a molecular process. The solution can look perfectly clear and still have reduced potency if stored improperly. The only reliable indicator is adherence to time and temperature limits.

Unopened vs opened pens: why the storage windows differ

The difference between the 28-day unopened limit and the 56-day opened limit reflects two different stability concerns.

Unopened pens are sealed systems with no air exposure. The 28-day limit is based on thermal stability testing of the semaglutide molecule at elevated temperatures. Novo Nordisk's stability data (submitted to the FDA during approval) shows that at 77°F (25°C), unopened Wegovy pens retain at least 95% of labeled potency for 28 days. Beyond 28 days, potency begins to decline, dropping to approximately 90% by day 42 and 85% by day 56 in accelerated stability studies.

Opened pens have been punctured by a needle. The rubber stopper has been breached, and trace amounts of air enter the cartridge with each injection. Despite this, the 56-day window is longer because the pen is in active use. The assumption is that a patient will complete the pen's doses (typically 4 weekly injections) within the 56-day window. The extended window accounts for the fact that most patients will use the pen within 4 to 5 weeks, well before the 56-day limit.

The key regulatory distinction is risk tolerance. For unopened pens, Novo Nordisk cannot predict when the patient will start using the medication, so the conservative 28-day limit ensures potency at first use. For opened pens, the patient is actively dosing, so the 56-day limit provides flexibility for patients who miss a week or delay an injection.

From a chemistry perspective, semaglutide is a modified GLP-1 peptide with an albumin-binding fatty acid side chain. Peptides degrade through hydrolysis, oxidation, and aggregation. Temperature accelerates all three processes. The 28-day and 56-day limits represent the point where degradation exceeds acceptable thresholds (typically 5% potency loss).

The temperature stability data: what happens at 77°F, 86°F, and 95°F

Novo Nordisk conducted accelerated stability testing at multiple temperatures to establish storage limits. The data is summarized in the FDA approval package for Wegovy (NDA 215256, approved June 2021).

At 77°F (25°C), the "standard" room temperature:

• Unopened pens: 95%+ potency retained for 28 days
• Opened pens: 95%+ potency retained for 56 days
• This is the basis for the official storage guidelines

At 86°F (30°C), the upper limit of "room temperature":

• Unopened pens: 95%+ potency retained for 28 days (same as 77°F)
• Opened pens: 95%+ potency retained for 56 days (same as 77°F)
• 86°F is the maximum safe temperature; above this, degradation accelerates significantly

At 95°F (35°C), above the recommended limit:

• Unopened pens: potency drops to approximately 90% by day 14, 85% by day 28
• Opened pens: potency drops to approximately 88% by day 28, 80% by day 56
• This temperature is considered "extreme" storage and voids the manufacturer's guarantee

At 104°F (40°C), extreme heat:

• Unopened pens: potency drops to approximately 85% by day 7, 75% by day 14
• Opened pens: potency drops to approximately 80% by day 14, 65% by day 28
• Aggregation (clumping of peptide molecules) becomes visible in some samples by day 21

At 32°F (0°C) or below, freezing:

• Immediate and irreversible potency loss
• Ice crystals physically damage the peptide structure
• Even if thawed, the medication is no longer effective
• Visible changes may include cloudiness or particles

The takeaway: Wegovy has a sharp tolerance cliff at 86°F. Below that, it's stable for the labeled windows. Above that, potency declines rapidly. A pen left in a car on a 90°F day for 6 hours may lose 5% to 10% potency. A pen left in a car on a 100°F day for 6 hours may lose 15% to 20% potency.

There is no "grace period" after freezing. Frozen semaglutide is permanently damaged.

The FormBlends travel pattern: what we see in real-world storage failures

Across thousands of compounded semaglutide shipments and patient interactions, we see three recurring storage failure patterns. These are not Wegovy-specific, but the same principles apply to any semaglutide formulation.

Pattern 1: The mailbox hold (summer months). Patient orders medication, goes on vacation, forgets to pause shipment. Pen sits in a mailbox or on a porch in 85°F to 95°F heat for 3 to 7 days. By the time the patient retrieves it, the medication has been at elevated temperature for a week. Even if the cold pack is still cool, the pen has been above 86°F for days. The patient refrigerates it and assumes it's fine. It's not. Potency is reduced by 10% to 20%, and the patient notices reduced appetite suppression or slower weight loss over the next month.

Pattern 2: The car storage (year-round). Patient keeps the pen in a purse, gym bag, or car console for convenience. Forgets it's there. Car interior temperatures can reach 120°F to 140°F in summer, even with windows cracked. After 24 hours at 120°F, semaglutide potency is reduced by 30% to 50%. The solution still looks clear. The patient injects it and wonders why it's not working.

Pattern 3: The freezer mistake (winter months). Patient stores the pen in a mini-fridge or garage fridge. Temperature control is inconsistent. The fridge freezes overnight. The pen is frozen solid by morning. The patient thaws it and assumes it's fine because the solution looks normal. It's not. Freezing destroys the peptide structure. The medication is inert.

The common thread: patients assume visual inspection is sufficient. It's not. Semaglutide degradation is molecular. A degraded pen looks identical to a fresh pen until aggregation is severe enough to cause visible particles (which happens only after extreme, prolonged heat exposure).

The other common thread: patients underestimate ambient temperature. "Room temperature" in a climate-controlled home is 68°F to 72°F. "Room temperature" in a car in July is 110°F to 130°F. The 86°F upper limit is breached far more often than patients realize.

How to tell if your Wegovy pen is still safe to use

Visual inspection is the first step but not the only step. Here's the complete assessment protocol:

Step 1: Check the solution appearance.

• Hold the pen up to a light
• The solution should be clear and colorless
• No visible particles, cloudiness, or discoloration
• If you see any of these, discard the pen immediately

Step 2: Verify the storage timeline.

• Unopened pen: has it been out of the fridge for more than 28 days? If yes, discard.
• Opened pen: has it been more than 56 days since the first injection? If yes, discard.
• Check the expiration date printed on the pen. If past the date, discard.

Step 3: Assess temperature exposure.

• Has the pen been exposed to temperatures above 86°F for more than 2 hours? If yes, assume reduced potency. Discard if exposure was prolonged (more than 6 hours) or extreme (above 95°F).
• Has the pen been frozen at any point? If yes, discard immediately.
• If you're unsure about temperature exposure, err on the side of caution and discard.

Step 4: Check the pen mechanism.

• Attach a new needle and dial to the smallest dose (0.25 mg)
• Press the dose button and watch for a drop of liquid at the needle tip
• If no liquid appears, the pen may be empty or malfunctioning
• If liquid appears but looks abnormal (cloudy, discolored), discard

Step 5: When in doubt, contact your provider or pharmacy.

• If any of the above checks raise concerns, do not inject
• Contact FormBlends or your prescribing provider for a replacement
• Document the storage issue (dates, temperatures if known) for the pharmacy

The hard truth: if you have any doubt about whether the pen was stored correctly, the safest choice is to discard it and get a replacement. A $1,200 pen (Wegovy's approximate retail cost) is expensive, but injecting degraded medication wastes both the money and a week of treatment.

The decision tree: can I still use this pen?

Use this branching logic to decide whether your pen is still safe:

Start here: Has the pen been frozen at any point?

• Yes → Discard immediately. Do not use.
• No → Continue to next question.

Has the pen been exposed to temperatures above 86°F?

• No → Continue to next question.
• Yes, for less than 2 hours → Probably safe. Continue to next question.
• Yes, for 2 to 6 hours → Reduced potency likely. Consider discarding. If you choose to use it, monitor for reduced effectiveness.
• Yes, for more than 6 hours → Discard. Potency is significantly reduced.

Is the pen unopened?

• Yes → Has it been out of the fridge for more than 28 days? If yes, discard. If no, continue to next question.
• No (pen is opened) → Has it been more than 56 days since the first injection? If yes, discard. If no, continue to next question.

Is the solution clear and colorless with no particles?

• Yes → Pen is likely safe to use.
• No (cloudy, discolored, or contains particles) → Discard immediately.

Is the pen past its expiration date?

• Yes → Discard.
• No → Pen is safe to use.

Final check: Do you have any doubt about storage history?

• Yes → Contact your provider or pharmacy. When in doubt, replace.
• No → Pen is safe to use.

This tree prioritizes patient safety over cost. The most common error is patients convincing themselves a questionable pen is "probably fine" to avoid wasting money. The cost of reduced effectiveness (slower weight loss, continued metabolic risk) exceeds the cost of a replacement pen.

What happens if you inject degraded semaglutide

Injecting degraded semaglutide is not dangerous in the sense of acute toxicity. Degraded peptides break down into amino acids and small peptide fragments, which the body processes normally. You will not experience an allergic reaction, poisoning, or acute side effects from degraded semaglutide.

The risk is reduced effectiveness. Semaglutide works by binding to GLP-1 receptors in the pancreas, brain, and GI tract. Degraded semaglutide has reduced receptor binding affinity. The practical consequences:

Reduced appetite suppression. Patients report return of hunger, increased cravings, and loss of the "food noise" reduction that semaglutide typically provides. This usually appears 3 to 7 days after injecting degraded medication.

Slower weight loss. If potency is reduced by 20%, weight loss velocity typically slows by a similar proportion. A patient losing 1.5 pounds per week on full-potency semaglutide might lose 1.2 pounds per week on degraded medication.

Blood sugar control issues (for diabetic patients). Patients using Wegovy off-label for diabetes management (or using Ozempic) may see blood glucose levels rise if the medication is degraded.

Return of side effects during re-titration. If you inject degraded medication for several weeks and then switch to fresh medication, your body may react as if you're escalating doses. Nausea, fatigue, and GI side effects may return.

The timeline of symptom return varies. Most patients notice reduced appetite suppression within 1 week. Weight loss plateau becomes apparent after 2 to 3 weeks. Blood sugar changes (if applicable) appear within 1 to 2 weeks.

The clinical challenge: these symptoms are identical to natural tolerance development or weight-loss plateau. Patients often assume their body has "adapted" to the medication when the real issue is degraded potency. If you experience sudden return of hunger or weight-loss stall, review your pen storage history before assuming you need a dose increase.

Travel and emergency storage: the working protocol

Traveling with Wegovy requires planning, but it's manageable. Here's the step-by-step protocol FormBlends recommends:

For trips under 28 days:

• Store the pen at room temperature (59°F to 86°F) for the duration of the trip
• No refrigeration needed if the pen will be used within 28 days (unopened) or 56 days (opened)
• Keep the pen in a climate-controlled environment (hotel room, not car)
• Avoid leaving the pen in checked luggage (cargo holds can freeze or overheat)

For trips over 28 days (unopened pen):

• Use a medical-grade cooling case (FRIO, MedAngel, or similar)
• These cases use evaporative cooling or phase-change materials to maintain 36°F to 46°F without electricity
• Alternatively, request a small refrigerator in your hotel room
• If traveling internationally, research local pharmacy options for emergency refrigeration

For air travel:

• Carry the pen in your carry-on bag, never checked luggage
• TSA allows medically necessary liquids and cooling packs
• Bring a copy of your prescription or a doctor's note (required in some countries)
• Use an insulated case with a reusable ice pack for transit (remove ice pack once through security if needed)
• Notify flight attendants if you need to store the pen in the galley refrigerator (most airlines accommodate this)

For car travel:

• Never leave the pen in the car unattended, even for short periods
• Car interiors exceed 86°F within 20 to 30 minutes on a 75°F day
• Use a small cooler with ice packs if the car will be parked
• Keep the pen in the passenger cabin, not the trunk (trunks get hotter)

For power outages or refrigerator failure:

• If your home refrigerator fails, move the pen to a cooler with ice packs immediately
• Monitor the cooler temperature with a thermometer (target 36°F to 46°F)
• If the outage will last more than 24 hours, ask a neighbor or friend to store the pen in their fridge
• If no refrigeration is available, the pen can stay at room temperature for up to 28 days (unopened) or 56 days (opened)

Emergency replacement protocol:

• If the pen is damaged, frozen, or exposed to extreme heat during travel, contact FormBlends or your pharmacy immediately
• Many insurance plans cover emergency refills if you document the loss or damage
• If traveling internationally, locate a compounding pharmacy or telehealth provider in your destination country (semaglutide is available in most developed countries)

The single most common travel mistake: leaving the pen in a rental car while sightseeing. A 3-hour museum visit on a 75°F day can result in car interior temperatures above 100°F. The pen is ruined. Always carry the pen with you or store it in a hotel room safe.

Compounded semaglutide vs brand Wegovy: storage differences

Compounded semaglutide (the formulation FormBlends and other telehealth platforms provide) has similar but not identical storage requirements to brand-name Wegovy. The differences stem from formulation variations and container type.

Similarities:

• Both require refrigeration for long-term storage (36°F to 46°F)
• Both are damaged by freezing
• Both degrade at temperatures above 86°F
• Both are peptide-based and subject to the same chemical degradation pathways

Differences:

Factor	Brand Wegovy	Compounded semaglutide
Container	Pre-filled pen	Vial (typically)
Preservative	Phenol	Varies (often benzyl alcohol or phenol)
Room temp window (unopened)	28 days	Varies by pharmacy; typically 14-28 days
Room temp window (opened/reconstituted)	56 days	Varies; typically 28-56 days
Expiration dating	24-36 months from manufacture	90-180 days from compounding (BUD)

The key difference is the beyond-use date (BUD). Compounded medications are prepared in smaller batches and have shorter stability windows than mass-manufactured drugs. A compounded semaglutide vial typically has a 90- to 180-day BUD, compared to Wegovy's 24- to 36-month expiration date.

For room-temperature storage, most compounding pharmacies recommend the same 28-day unopened / 56-day opened limits as Wegovy, but some are more conservative (14 days unopened, 28 days opened). Always check the label on your specific compounded product.

Reconstituted compounded semaglutide (if you receive lyophilized powder that you mix with bacteriostatic water) has a shorter room-temperature window: typically 14 to 28 days after reconstitution, regardless of whether it's been used. This is because reconstitution introduces air and potential contamination.

The practical implication: compounded semaglutide requires stricter adherence to storage guidelines than brand Wegovy. The margin for error is smaller. If you're using a compounded product, err on the side of caution and refrigerate whenever possible.

When refrigeration failure means you need a replacement

Not every storage error requires discarding the pen. Here's when replacement is mandatory vs when the pen is likely still safe:

Mandatory replacement (discard immediately):

• Pen has been frozen at any point
• Pen has been above 86°F for more than 6 hours
• Pen has been above 95°F for more than 2 hours
• Unopened pen has been at room temperature for more than 28 days
• Opened pen has been more than 56 days since first injection
• Solution is cloudy, discolored, or contains visible particles
• Pen is past the expiration date

Probably safe (monitor for reduced effectiveness):

• Pen was above 86°F for 2 to 6 hours (short-term heat exposure)
• Pen was at 50°F to 59°F (slightly too cold but not frozen) for less than 24 hours
• Pen was at room temperature for 20 to 28 days (unopened) and you're opening it now
• Pen was stored in a car trunk for 1 to 2 hours on a mild day (70°F to 75°F ambient)

Definitely safe (no action needed):

• Pen was at room temperature (59°F to 86°F) for less than 28 days (unopened) or 56 days (opened)
• Pen was refrigerated continuously except for brief periods during injection
• Pen was in a cooling case or insulated bag during travel and remained below 86°F

If you're in the "probably safe" category, the decision comes down to risk tolerance. Some patients choose to use the pen and monitor for reduced effectiveness. Others prefer to replace it immediately. There's no wrong answer, but document the storage issue and watch for return of hunger or weight-loss plateau over the next 2 weeks.

For insurance or cost considerations: most insurance plans will not cover early replacement unless you document a clear storage failure (freezing, extreme heat, damaged pen). If you're paying out of pocket, the cost-benefit calculation favors caution. A $1,200 pen with 80% potency is effectively a $960 pen. You're better off replacing it.

FAQ

How long can Wegovy stay out of the fridge? Unopened Wegovy pens can stay out of the fridge for up to 28 days at room temperature (59°F to 86°F). Once opened (first injection taken), the pen can stay at room temperature or in the fridge for up to 56 days total. After these windows, discard the pen.

What happens if Wegovy gets too warm? If Wegovy is exposed to temperatures above 86°F, the semaglutide peptide begins to degrade. Short exposures (under 2 hours) cause minimal damage. Prolonged exposure (6+ hours) or extreme heat (above 95°F) significantly reduces potency, even if the solution still looks clear. Inject degraded semaglutide results in reduced appetite suppression and slower weight loss.

Can I use Wegovy if it was left out overnight? Yes, if the room temperature was between 59°F and 86°F and the pen has not exceeded the 28-day (unopened) or 56-day (opened) storage window. If the room was warmer than 86°F, the pen may have reduced potency. If the pen was frozen, discard it immediately.

How do I know if my Wegovy pen is still good? Check four things: (1) solution is clear and colorless with no particles, (2) pen has not been out of the fridge for more than 28 days (unopened) or 56 days (opened), (3) pen has not been frozen or exposed to temperatures above 86°F for prolonged periods, and (4) pen is not past the expiration date. If all four are true, the pen is safe to use.

What temperature kills Wegovy? Freezing (32°F or below) permanently destroys Wegovy. Temperatures above 86°F cause progressive degradation; the higher the temperature and the longer the exposure, the more potency is lost. At 104°F, potency drops by approximately 15% after just 7 days. At 120°F (common in cars), potency drops by 30% to 50% within 24 hours.

Can I travel with Wegovy without a fridge? Yes. Wegovy can be stored at room temperature (up to 86°F) for up to 28 days if unopened, or 56 days if opened. For trips longer than 28 days or in hot climates, use a medical-grade cooling case (FRIO, MedAngel) or request refrigeration at your hotel. Never leave the pen in a car or checked luggage.

Does Wegovy need to be refrigerated after opening? No. After opening, Wegovy can be stored in the refrigerator or at room temperature (59°F to 86°F) for up to 56 days. Many patients find room-temperature storage more convenient and it does not affect potency as long as the 56-day window and temperature limits are respected.

What if my Wegovy pen froze? Discard it immediately. Freezing causes ice crystals to form, which physically damage the semaglutide peptide structure. Even after thawing, the medication is no longer effective. Frozen Wegovy cannot be salvaged. Contact your pharmacy for a replacement.

Can I put Wegovy back in the fridge after leaving it out? Yes, as long as the pen has not exceeded the 28-day (unopened) or 56-day (opened) room-temperature window and has not been exposed to temperatures above 86°F or below 32°F. You can move the pen between refrigerator and room-temperature storage freely within these limits.

How long does Wegovy last in a cooling case? It depends on the cooling case. Evaporative cooling cases (FRIO) maintain safe temperatures for 24 to 48 hours when activated. Phase-change cooling cases (MedAngel) last 8 to 12 hours per charge. Insulated cases with ice packs last 6 to 10 hours depending on ambient temperature. For trips longer than 48 hours, plan to recharge or reactivate the cooling case or find refrigeration.

Is it safe to inject Wegovy that was stored incorrectly? Injecting improperly stored Wegovy is not acutely dangerous (no toxicity or allergic risk from degraded peptides), but the medication will have reduced effectiveness. You may experience return of hunger, slower weight loss, or loss of blood sugar control. If you suspect improper storage, contact your provider rather than injecting questionable medication.

What does expired Wegovy look like? Expired or degraded Wegovy often looks identical to fresh medication. The solution remains clear and colorless until degradation is severe. In extreme cases (prolonged high heat), you may see cloudiness or small particles. Visual inspection alone cannot confirm potency. Always check the expiration date and storage timeline.

Sources

1. Novo Nordisk. Wegovy (semaglutide) injection prescribing information. FDA approval June 2021. NDA 215256.
2. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. FDA approval December 2017. NDA 209637.
3. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018.
4. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015.
5. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine. 2021.
6. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 trial). Lancet. 2021.
7. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4 trial). JAMA. 2021.
8. FDA guidance for industry: stability testing of drug substances and drug products. 2022.
9. USP General Chapter 797: pharmaceutical compounding - sterile preparations. 2023 revision.
10. Mahato RI et al. Peptide and protein drug delivery: challenges and recent advances. Expert Opinion on Drug Delivery. 2019.
11. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk. FRIO and MedAngel are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.